Pharming Group N.V. (PHAR)
NASDAQ: PHAR · Real-Time Price · USD
12.95
+0.33 (2.59%)
May 12, 2026, 11:26 AM EDT - Market open

Pharming Group Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
19.8812.85-8.49-12.0114.9923.08
Depreciation & Amortization
11.7511.2216.0715.9313.1919.61
Stock-Based Compensation
14.4213.7711.259.256.399.06
Other Adjustments
4.199.02-0.17-15.73-10.57-8.99
Change in Receivables
-13.14-3.36-6.78-18.542.365.92
Changes in Inventories
-0.47-1.29-0.5-14.43-15.02-6.15
Changes in Accounts Payable
22.2714.13-2.7716.2311.99-5.19
Changes in Income Taxes Payable
-4.93-4.6-15.58-0.66-1.24-
Changes in Other Operating Activities
1.272.975.182.670.360.52
Operating Cash Flow
56.4354.71-1.8-17.322.4637.84
Operating Cash Flow Growth
827.48%----40.65%-54.75%
Capital Expenditures
-0.71-0.75-0.79-1.44-1.38-10.74
Purchases of Intangible Assets
--0.01-0.01-0.03-0.6-5.98
Proceeds from Sale of Intangible Assets
---21.28--
Purchases of Investments
-102.98-0.74-284.31-382.01--4.59
Proceeds from Sale of Investments
35.4885.23316.73232.817.3-
Payments for Business Acquisitions
--57.48----
Investing Cash Flow
-68.226.2531.62-129.395.32-21.31
Long-Term Debt Issued
--104.54---
Long-Term Debt Repaid
-16.51-4.25-138.93-4.04-3.31-3.22
Net Long-Term Debt Issued (Repaid)
-16.51-4.25-34.39-4.04-3.31-3.22
Other Financing Activities
16.725.74-0.023-1.67-24.73
Financing Cash Flow
-1.011.5-34.41-1.04-4.98-27.95
Effect of Exchange Rate Changes on Cash and Cash Equivalents
5.077.91-2.212.13-7.38-1.83
Net Cash Flow
-12.7882.45-4.59-147.7322.8-11.41
Free Cash Flow
55.7253.96-2.59-18.7421.0827.1
Free Cash Flow Growth
3.27%----22.21%-65.68%
FCF Margin
15.08%14.35%-0.87%-7.64%10.25%13.63%
Free Cash Flow Per Share
0.750.72-0.03-0.260.300.39
Levered Free Cash Flow
24.8720.28-44.633.7118.2710.82
Unlevered Free Cash Flow
67.947.52-7.0112.9127.7411.61
Updated May 7, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q